How Pyramid Pharma Services is Adapting to Industry Trends and Emerging Drug Modalities.

“…beyond technical capabilities, the nature of CDMO client relationships is changing. Pharmaceutical companies are moving away from transactional engagements and seeking long-term strategic partnerships. Alignment on business strategy, culture, and operational philosophy is now a critical factor in vendor selection.

Growth was largely organic, driven by quality performance and word-of-mouth referrals. In 2023, Audax Private Equity acquired the company, bringing in an experienced management team and investing in expansion initiatives. This includes the launch of a high-speed fill line for pre-filled syringes, cartridges, and vials—enhancing Pyramid’s ability to support large-scale commercial programs." – Dirk Lange, CEO Pyramid Pharma Services

You can find the full insightful interview by Global Business Reports (GBR) with Dirk T. Lange in the following link: GBR Pyramid Interview